SRT Combined With Anlotinib for the Treatment of Brain Metastases From Non-small Cell Lung Cancer

NARecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

February 28, 2027

Conditions

Non-Small-Cell Lung CancerBrain Metastases

Interventions

DRUG

Anlotinib hydrochloride

Anlotinib#12mg#PO#Q3W#d1-14# SRT#depends

Trial Locations (1)

RECRUITING

The First People's Hospital of Lianyungang, Lianyungang

All Listed Sponsors

lead

The First People's Hospital of Lianyungang

OTHER